Clinical Trial Update: A Study to Investigate the Potential Pharmacokinetic Interaction Between TMC435 and Methadone [Phase 1]

View source ↗

Summary

Phase 1 study evaluating potential pharmacokinetic interaction between TMC435 and methadone in Hepatitis C patients; the trial has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Methadone (methadone)
• TMC435

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED